Evidence map›Paper›PMID 41464508›Full record

ArticleInternational journal of environmental research and public health2025

Prenatal Exposure to Phthalates, Bisphenols and Their Mixtures and Early Childhood Allergic Conditions and Asthma: Results from the APrON Cohort.

Emily Bartram, Gillian England-Mason, Jonathan W Martin, Amy M MacDonald, David W Kinniburgh, Deborah Dewey, Munawar Hussain Soomro, APrON Study Team

Abstract read
In one paragraph

Article in International journal of environmental research and public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Emily BartramDepartment of Biological Sciences, University of Calgary, Calgary, AB T2N 1N4, Canada.ORCID 0009-0000-9435-072X
Gillian England-MasonDepartment of Pediatrics, Cumming School of Medicine, University of Calgary, Calgary, AB T3B 6A8, Canada.ORCID 0000-0003-0633-5963
Jonathan W MartinScience for Life Laboratory, Department of Environmental Science, Stockholm University, 114 18 Stockholm, Sweden.
Amy M MacDonaldAlberta Centre for Toxicology, University of Calgary, Calgary, AB T2N 4N1, Canada.ORCID 0000-0001-7031-8952
David W KinniburghAlberta Centre for Toxicology, University of Calgary, Calgary, AB T2N 4N1, Canada.
Deborah DeweyDepartment of Pediatrics, Cumming School of Medicine, University of Calgary, Calgary, AB T3B 6A8, Canada.ORCID 0000-0002-1323-5832
Munawar Hussain SoomroDepartment of Pediatrics, Cumming School of Medicine, University of Calgary, Calgary, AB T3B 6A8, Canada.ORCID 0000-0002-9573-2591
APrON Study Team

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Associations between prenatal exposure to phthalates, bisphenols and their mixtures and early childhood allergic conditions and asthma were examined. Five hundred and fifty-six mother-child pairs from the Alberta Pregnancy Outcomes and Nutrition (APrON) cohort participated. Urine samples collected from mothers during the second trimester of pregnancy were analyzed for phthalates and bisphenols. A child health questionnaire, completed by mothers when children were 12, 24, and 36 months, asked whether children had experienced allergic conditions (i.e., food allergies, eczema, rash) or asthma. In single-chemical models, associations varied with child age. Higher prenatal concentrations of mono-benzyl phthalate (MBzP) were associated with lower odds of eczema at 12 months. At 36 months, higher mono-methyl phthalate (MMP) was associated with increased odds of eczema, whereas higher mono-carboxy-octyl phthalate (MCOP) was associated with reduced odds. Higher prenatal MCOP was also associated with higher odds of rash at 12 months, and higher MMP was associated with higher odds of rash at 36 months. Higher bisphenol S (BPS) was associated with increased odds of asthma at 12 months but decreased odds of eczema and rash at 36 months. Sex-specific effects were also noted. In multi-chemical exposure least absolute shrinkage and selection operator (LASSO) models, several phthalate metabolites and BPS were selected as the best predictors of eczema and rash at 36 months of age. Bayesian kernel machine regression (BKMR) mixture models suggested that BPS was the most important chemical in predicting eczema in children at 36 months, while MMP and BPS were the most important chemicals in predicting rash at 36 months. Prenatal exposure to certain phthalate metabolites and BPS predicted allergic conditions and asthma in young children, with patterns varying by age and sex. Prenatal exposure to these chemicals may differentially influence immune development and contribute to the development of early-life allergic conditions, with potentially sex-specific susceptibility.

Indexed as

AsthmaBenzhydryl CompoundsEnvironmental PollutantsHypersensitivityMaternal ExposurePhenolsPhthalic AcidsPrenatal Exposure Delayed EffectsAdultAlbertaBisphenolsChild, PreschoolCohort StudiesFemaleHumansInfantBenzhydryl CompoundsBisphenolsEnvironmental PollutantsPhenolsphthalic acidPhthalic Acidsallergic conditionsAPrONasthmabisphenolsearly childhoodphthalates

Identifiers

PMID41464508
PMCPMC12732642

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.